key: cord-0837790-xa1j1ivm authors: Molina‐Gil, Javier; González‐Fernández, Lucía; García‐Cabo, Carmen title: Trigeminal neuralgia as the sole neurological manifestation of COVID‐19: A case report date: 2021-03-22 journal: Headache DOI: 10.1111/head.14075 sha: f5e330bb90ac8e97c5f71088c273d76ef2239dfd doc_id: 837790 cord_uid: xa1j1ivm OBJECTIVE: To describe a case report of trigeminal neuralgia (TN) due to coronavirus disease‐2019 (COVID‐19). BACKGROUND: In March 2020, the World Health Organization declared COVID‐19 as a pandemic. Respiratory system manifestations are dominant in this new disease. However, numerous case series and reviews have been published on the neurological manifestations, highlighting the potential neurotropism of the new coronavirus. METHODS: We describe a clinical case of TN during COVID‐19 and we discuss the differential diagnosis and the potential pathogenic mechanism according to the literature. RESULTS: A 65‐year‐old man with general malaise and typical respiratory symptoms of COVID‐19, who presented with paroxysmal lancinating pain in the right V1 trigeminal territory without other neurological symptoms. General blood test and neuroimaging study were normal. A rapid test showed positive IgG and IgM serologies for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). The patient was diagnosed with TN secondary to a viral infection by SARS‐CoV‐2. Facial pain resolved with the improvement of COVID‐19. CONCLUSIONS: The new coronavirus SARS‐CoV‐2 is a possible etiology of secondary TN. Nevertheless, more studies are needed to elucidate the neuropathology of this viral infection. | 561 HEADACHE the infectious symptoms and it was not related to fever. Hemicranial involvement was predominant and patients described a worsening of the pain with head movements and exercise. Two patients in the sample experienced pain resembling electric shock, without following a certain nerve territory. The existence of TN in relation to SARS-CoV-2 infection was not identified. 6 Mao et al. registered five cases of nerve pain in their series of neurological manifestations of COVID-19, without specifying the nerve territory compromised or the pain characteristics. 3 We present the case of a 65-year-old man, with no medical history, who began with general malaise, arthromyalgia, dry cough, and lowgrade fever. On the third day, he noted paroxysmal lancinating pain in the right V1 region that lasted a few seconds and was triggered by a light touch of the skin at a specific point on the scalp. The patient did not mention other neurological symptoms such as anosmia or ageusia. On physical examination, there were no vesicular skin lesions or sensory loss in that location, and no associated autonomic symptoms. Three days after the onset of pain, the patient developed a fever of 38.5ºC and experienced a clinical worsening of the pain. He consulted his general practitioner, who prescribed pregabalin 300 mg and diazepam 10 mg per day for the pain, and recommended home quarantine due to a high suspicion of COVID-19. The patient did not respond to pharmacological treatment and decided to abandon it after a few days. However, the pain resolved with the improvement of COVID-19-specific symptoms. To carry out a complete etiological study, a cranial magnetic resonance (MR) with MR angiography was performed and it was normal with no evidence of vascular contact with TN. Blood tests, which included blood count, infectious serologies, and renal, liver and thyroid function, were normal. Although PCR test was negative, rapid test showed positive IgM and IgG serologies for SARS-CoV-2, and an initial analysis showed a slight elevation of the D-dimer of 800 ng/ml (upper limit: 500 ng/ml). Due to these results, the patient was diagnosed with TN secondary to a viral infection by SARS-CoV-2. We obtained the written informed consent of the patient and ethical board approval to communicate this clinical case. TN is defined as unilateral and lancinating facial pain with an abrupt onset and termination. It could be triggered by innocuous stimuli and its distribution is restricted to one or more trigeminal subdivisions. TN can develop for no apparent reason or be caused by another diagnosed disorder. Its prevalence is estimated to be in 0.07% and it is more frequent in women over 50 years of age. Right hemifacial involvement predominates in this type of neuralgia and V1 involvement is uncommon. 7, 8 In the differential diagnosis of TN, it is worth highlighting trigeminal neuropathy, which is usually accompanied by sensory loss and a longer duration of pain, 9 and trigeminal autonomic cephalalgias such as SUNCT (short-lasting unilateral neuralgiform headache attacks with conjunctival inyection and tearing) and SUNA (short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms), whose main characteristics are being accompanied by autonomic symptoms. 10 The patient described here, did not present the characteristic symptoms of these headaches in any case. Regarding its etiology, half of patients with TN have the idiopathic subtype while classical TN is due to a neurovascular compression of the trigeminal root that was not found in our patient. Alternatively, secondary TN can be due to multiple sclerosis, cerebellopontine angle tumors, and other pathologies. 7 Some authors suggest a direct mechanism of headache and fa- The case presented has its limitations. Despite being an accurate description of TN, the mechanisms by which the SARS-CoV-2 activates the nerve and causes it to trigger pain are not yet clear. More studies are needed to elucidate the neurological manifestation of the SARS-CoV-2 infection. The authors of this manuscript declare no conflict of interest. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical features of patients infected with 2019 novel coronavirus in Wuhan Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China Neurological manifestations of COVID-19: a systematic review and current update Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry Spectrum of headaches associated with SARS-CoV-2 infection: study of healthcare professionals Headache Classification Committee of the International Headache Society (IHS) A comprehensive review of trigeminal neuralgia Trigeminal neuralgia. Continuum (Minneap Minn The fifth cranial nerve in headaches Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms COVID-19 and headache: a primer for trainees Trigeminal neuralgia as the sole neurological manifestation of COVID-19: A case report